Bixiye
QP18-18 Medical Drug Exclusion Lists Expanded to Include Ixifi, Durolane, Visco 3 and TriVisc
Taariikhda uu dhaqangalayo Barnaamijka: Mar 08, 2018
Natiijooyinka Raadinta
Soo bandhiga 2901 - 2910 ee natiijooyinka 4130
Bixiye
QP41-18 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP33-17 ICD-10 Grouper Updates
Taariikhda uu dhaqangalayo barnaamijka: Okt 17, 2017
Bixiye
QP10-18 Routes of Administration Pharmacy Benefit Exclusion
Taariikhda uu dhaqangalayo Barnaamijka: 05, Feb 2018
Bixiye
QP21-17 New Pre-Authorization Forms for Bariatric Surgery, Lumbar Fusion and Percutaneous Facet Joint Denervation
Taariikhda barnaamijka Dhaqangalayso Agosto 08, 2017
Bixiye
QP14-17 McKesson Interqual Criteria Update
Taariikhda dhaqangalka Barnaamijka: Jul 05, 2017
Bixiye
QP89-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Circadian Rhythm Disorder
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2018
Bixiye
QP32-17 Pharmacy Benefit Update - Dispense as Written (DAW) 1 Clarification
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2017
Bixiye
QP91-18 Addition of Drug to the Thrombopoietin Receptor Agonists Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2018
Bixiye
QP80-18 Universal Pharmacy Policy for MHCP Subscribers - Immediate Release and Extended Release Opioids Initial Fill Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 24, 2018